← Leaderboards
Scott Dryden-Peterson
Brigham And Women'S Hospital
$3,779,420
Attributed
$4,361,257
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $738.5K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,361,257 · 3
By mechanism
R01$2,539,046 · 1
UG1$1,163,675 · 1
K23$658,536 · 1
Top collaborators
- Doreen Ramogola-Masire5 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Eric Garland Sheu$3,405,774
- Chunling Lu$820,050
- Scott Gordon Weiner$2,904,452
- Joseph J Rhatigan$44,750
Others in their field
Top investigators on “Botswana”
- Myron E Essex · Harvard University (Sch Of Public Hlth)$94,718,448
- Myron S Cohen · Family Health International$36,604,553
- Daniel R Kuritzkes · Brigham And Women'S Hospital$28,847,944
- Roger L Shapiro · Harvard University (Sch Of Public Hlth)$27,075,534
- Shahin Lockman · Harvard University D/B/A Harvard School Of Public Health$21,221,162
- Tendani Gaolathe · Botswana-Harvard Aids Institute$17,256,047
Research focus
BotswanaResourcesCohortCountryCessation Of LifeMentorsProgramsCaringOncologyHealth SystemCause Of DeathCancer TherapyMalignant NeoplasmsMortalityAgedEarly DiagnosisInnovationHiv DiagnosisEffectivenessIncomeInternationalCommunitiesAffectAcquired Immunodeficiency Syndrome
Grant awards (16)
Botswana CASCADE Clinical Trials Site$300,208
UG1 · FY2025 · CA · contact PI
Botswana CASCADE Clinical Trials Site$1
UG1 · FY2025 · CA · contact PI
Botswana CASCADE Clinical Trials Site$367,640
UG1 · FY2024 · CA · contact PI
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation$469,486
R01 · FY2023 · CA · contact PI
Botswana CASCADE Clinical Trials Site$238,011
UG1 · FY2023 · CA · contact PI
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation$480,691
R01 · FY2022 · CA · contact PI
Botswana CASCADE Clinical Trials Site$257,815
UG1 · FY2022 · CA · contact PI
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation$479,108
R01 · FY2021 · CA · contact PI
Covid-19-related cervical cancer treatment interruption and role of neoadjuvant chemotherapy$136,011
R01 · FY2021 · CA · contact PI
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation$478,366
R01 · FY2020 · CA · contact PI
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation$495,384
R01 · FY2019 · CA · contact PI
Risk factors for early morbidity and mortality of HIV-exposed uninfected infants$127,720
K23 · FY2016 · AI · contact PI
Risk factors for early morbidity and mortality of HIV-exposed uninfected infants$128,504
K23 · FY2015 · AI · contact PI
Risk factors for early morbidity and mortality of HIV-exposed uninfected infants$131,637
K23 · FY2014 · AI · contact PI
Risk factors for early morbidity and mortality of HIV-exposed uninfected infants$133,771
K23 · FY2013 · AI · contact PI
Risk factors for early morbidity and mortality of HIV-exposed uninfected infants$136,904
K23 · FY2012 · AI · contact PI